BI 771716

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 771716, covering 2025-02-18 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]

See pricing